Literature DB >> 29787366

Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis.

Antonietta Gigante1, Domenico Margiotta2, Luca Navarini2, Marta Liberatori3, Biagio Barbano3, Luigi Tubani3, Antonella Afeltra2, Edoardo Rosato3.   

Abstract

OBJECTIVES: The imbalance between angiogenic and angiostatic factors with derangement of the microvasculature are hallmarks of systemic sclerosis (SSc). Raynaud's phenomenon in SSc probably is due to the impaired neuroendothelial control mechanisms between vasoconstriction and vasodilatation. The aim of this study is to evaluate autonomic nervous system function using heart rate variability (HRV) analysis and to correlate with vascular endothelial growth factor (VEGF).
METHODS: Twenty-seven SSc patients were enrolled. HRV was measured and markers of global sympathetic and parasympathetic system, respectively standard deviation of normal-to-normal RR intervals (SDNN) and square root of the mean of the sum of the squares of differences between adjacent NN intervals (RMSSD) were evaluated. Serum VEGF levels and nailfold videocapillaroscopy (NVC) were performed.
RESULTS: A linear positive correlation was observed between RMSSD and VEGF (p<0.01, r=0.55), and RMSSD and disease duration (p< 0.01, r=0.54). The RMSSD median value was significantly increased (p< 0.05) with NVC damage progression. The RMSSD median value was significantly (p<0.05) higher in SSc patients with digital ulcers (DUs) than in SSc patients without DUs [44 (39.4-60.2) vs 24.6 (23-37.1)].
CONCLUSIONS: In our study parasympathetic modulation increases in relation to VEGF. When microcirculation is modified with capillaroscopic pattern progression and DUs, autonomic system seems to stimulate vasodilatation trough parasympathetic system. We can conclude that parasympathetic activity increases with digital microvascular damage and promotes VEGF release.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29787366

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement.

Authors:  Francesco Iannazzo; Chiara Pellicano; Amalia Colalillo; Cesarina Ramaccini; Antonella Romaniello; Antonietta Gigante; Edoardo Rosato
Journal:  Clin Exp Med       Date:  2022-07-25       Impact factor: 5.057

2.  Cardiovascular Autonomic Control, Sleep and Health Related Quality of Life in Systemic Sclerosis.

Authors:  Angelica Carandina; Chiara Bellocchi; Gabriel Dias Rodrigues; Lorenzo Beretta; Nicola Montano; Eleonora Tobaldini
Journal:  Int J Environ Res Public Health       Date:  2021-02-25       Impact factor: 3.390

Review 3.  The Interplay between Autonomic Nervous System and Inflammation across Systemic Autoimmune Diseases.

Authors:  Chiara Bellocchi; Angelica Carandina; Beatrice Montinaro; Elena Targetti; Ludovico Furlan; Gabriel Dias Rodrigues; Eleonora Tobaldini; Nicola Montano
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

4.  Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies.

Authors:  Shunya Nakane; Masataka Umeda; Shin-Ya Kawashiri; Akihiro Mukaino; Kunihiro Ichinose; Osamu Higuchi; Yasuhiro Maeda; Hideki Nakamura; Hidenori Matsuo; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2020-02-21       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.